IL1B and Alzheimer disease: Furthermore, using nocturnal PSG and sleep scale (ESS) data in the present study, we found a strong and consistent assocaition between the IL-1β-31 promoter TT genotype and sleep disturbances in the daytime (ESS score) and nighttime (REM latency, REM%, and SWS%) of AD patients compared to the healthy controls.